Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Musculoskeletal Problems in School Children During the COVID-19 Pandemic

Musculoskeletal Problems and Associated Factors in Children Aged Between 6-13 Years During the COVID-19 Pandemic

During COVID-19 pandemic, in the lockdown period, reduced physical activity and obesity were reported in children.

In Turkey, face to face education was ceased after March 16, till the end of the previous academic year and education was tried to be substituted remotely.

A temporary lockdown was implemented for children and young people under the age of 20, between April 3 and June 5 2020. At 45 days following the lockdown of children, 72% of the parents with children aged 6-13 years stated that their screen time had increased to a mean of 6.4 hours per day.

Engaging more time in physical activity, and less in sedentary and leisure screen time was found to be associated with less anxiety during pandemic.

Before 2020-2021 academic year, government and educators increased their preparedness for the second and third waves and improved the technological infrastructure. Depending on grades, preferences of the family, primary education continued remotely between November 2020 and July 2021.

The aim of this study is to investigate whether musculoskeletal complaints are increased in school-age children during the pandemics and whether there is a relationship between the decreased level of physical activity, increased screen time, poor posture and musculoskeletal complaints.

Studieoversikt

Status

Påmelding etter invitasjon

Detaljert beskrivelse

A survey assessing musculoskeletal pain in children in the last 1 month, and associated factors including presence of non-ergonomic postures during online education was structured by two physiatrists and a public health specialist after the review of the relevant literature. Several paediatric pain and musculoskeletal assessment tools were reviewed.

The survey consisted of a total of 66 questions including sociodemographic characteristics of the children and family (17 items), education hours, used technological device (7 items), screen time and physical activity (5 items), presence of musculoskeletal pain (27 items) and ergonomics (10 items).

Questions regarding the musculoskeletal pain were constructed based on The Nordic musculoskeletal questionnaire extended version (NMQ-E) which was translated and validated into Turkish. Pain or discomfort questions experienced in the nine body parts with binary choices (yes or no) were used. The figure in NMQ-E was used to describe body regions (the neck, shoulder, upper back, elbow, wrist/hand, low back, hip/ thigh, knee, ankle/foot) and pain questions were structured accordingly on this body diagram.

The questionnaire was created using the Qualtrics program. The survey was piloted among ten participants to ensure its readability and ease of completion. After obtaining permissions from Ministry of National Education of Turkey, survey link was shared with the school principles so that they distributed the survey to the guardians of children via smart phones or email. The survey will be available during two months and a reminder will be sent once a week.

Studietype

Observasjonsmessig

Registrering (Forventet)

1225

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Gaziosmanpasa
      • Istanbul, Gaziosmanpasa, Tyrkia, 34255
        • Gaziosmanpasa Training and Research Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

6 år til 13 år (Barn)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Sannsynlighetsprøve

Studiepopulasjon

A sample size of 1225 participants was calculated by assuming a musculoskeletal pain prevalence of 15% among children between the ages 6-13, with a confidence limit of 95% with a margin of error 2%.

Beskrivelse

Inclusion Criteria:

  • Being parent or guardian of a child between the ages of 6-13 years
  • Having access to the Internet
  • Being literate
  • Giving consent to participate in the study

Exclusion Criteria:

  • Children going to special education school

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Presence of musculoskeletal pain
Tidsramme: One day
Presence of musculoskeletal pain in one of the nine body parts
One day

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Özden Özyemişçi Taşkıran, Prof, Koc University School of Medicine Department of Physical Medicine and Rehabilitation
  • Studieleder: Sibel Sakarya, Prof, Koc University School of Medicine Department of Infectious Disease
  • Studiestol: Zeynep Turan, Koc University School of Medicine Department of Physical Medicine and Rehabilitation
  • Studiestol: Esra Giray, Assoc Prof, Koc University School of Medicine Department of Physical Medicine and Rehabilitation

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. mai 2021

Primær fullføring (Forventet)

9. juli 2021

Studiet fullført (Forventet)

30. september 2021

Datoer for studieregistrering

Først innsendt

6. juli 2021

Først innsendt som oppfylte QC-kriteriene

6. juli 2021

Først lagt ut (Faktiske)

8. juli 2021

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

8. juli 2021

Siste oppdatering sendt inn som oppfylte QC-kriteriene

6. juli 2021

Sist bekreftet

1. juli 2021

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere